<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">115012</article-id><article-id pub-id-type="doi">10.17816/dv115012</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DERMATO-ONCOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДЕРМАТООНКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Difficulties in diagnosing ALK-negative anaplastic large cell lymphoma manifesting from a skin lesion</article-title><trans-title-group xml:lang="ru"><trans-title>Трудности диагностики ALK-негативной анапластической крупноклеточной лимфомы, манифестировавшей с поражения кожи</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8724-0714</contrib-id><contrib-id contrib-id-type="researcherid">rid33435</contrib-id><contrib-id contrib-id-type="spin">5143-7381</contrib-id><name-alternatives><name xml:lang="en"><surname>Bulanova</surname><given-names>Natalia V.</given-names></name><name xml:lang="ru"><surname>Буланова</surname><given-names>Наталья Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>kmn.nv.bulanova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8129-8114</contrib-id><contrib-id contrib-id-type="spin">8926-3289</contrib-id><name-alternatives><name xml:lang="en"><surname>Semochkin</surname><given-names>Sergey V.</given-names></name><name xml:lang="ru"><surname>Семочкин</surname><given-names>Сергей Вячеславович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>semochkin_sv@rsmu.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Volgograd Regional Clinical Oncology Center</institution></aff><aff><institution xml:lang="ru">Волгоградский областной клинический онкологический диспансер</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">P. Hertsen Moscow Oncology Research Institute, National Medical Research Radiological Center</institution></aff><aff><institution xml:lang="ru">Московский научно-исследовательский онкологический институт имени П.А. Герцена, филиал Национального медицинского исследовательского центра радиологии</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">The Russian National Research Medical University named after N.I. Pirogov</institution></aff><aff><institution xml:lang="ru">Российский национальный исследовательский медицинский университет имени Н.И. Пирогова</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-01-29" publication-format="electronic"><day>29</day><month>01</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2022-12-17" publication-format="electronic"><day>17</day><month>12</month><year>2022</year></pub-date><volume>25</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>25</fpage><lpage>32</lpage><history><date date-type="received" iso-8601-date="2022-12-01"><day>01</day><month>12</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-12-24"><day>24</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Bulanova N.V., Semochkin S.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Буланова Н.В., Семочкин С.В.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Bulanova N.V., Semochkin S.V.</copyright-holder><copyright-holder xml:lang="ru">Буланова Н.В., Семочкин С.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-02-17"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/115012">https://rjsvd.com/1560-9588/article/view/115012</self-uri><abstract xml:lang="en"><p>Anaplastic large cell lymphoma is a rare form of non-Hodgkin's lymphoma that requires an early diagnosis and urgent therapy due to aggressive tumor process. Clinically, most non-Hodgkin's lymphoma present with lymphoadenopathy and В-symptoms (such as weakness, drowsiness, fatigue, subfebrile fever, profuse night sweats). However, anaplastic large cell lymphoma may present with nonspecific skin lesions with minimal or no B-symptoms. The skin lesions are heterogeneous, which may also delay verification of the diagnosis.</p> <p>We present a case of widespread anaplastic large cell lymphoma skin lesions mimicking a case of erysipelas, which progressed rapidly from a single rash on the wrist to an extensive lesion of the right breast within 1 month. Prior to verification of the diagnosis, the patient was treated for erysipelas, pyoderma, and herpes zoster with no response to therapy. Immunohistochemical examination of a skin biopsy confirmed the diagnosis of ALK-negative anaplastic large cell lymphoma. At the time of publication, the patient had completed 1 course of the CHOEP regimen, and 6 cycles of the program were planned.</p> <p>Our case demonstrates the necessity of a broad differential diagnosis of rashes torpid to the current therapy.</p></abstract><trans-abstract xml:lang="ru"><p>Анапластическая крупноклеточная лимфома ― достаточно редкая форма неходжкинской лимфомы, которая требует своевременной диагностики и безотлагательного начала терапии ввиду агрессивности опухолевого процесса. Клинически бÓльшая часть неходжкинских лимфом манифестирует лимфаденопатией и симптомами опухолевой интоксикации (слабость, сонливость, утомляемость, повышение температуры тела до субфебрильных значений, профузные ночные поты). Однако анапластическая крупноклеточная лимфома может дебютировать с неспецифического поражения кожи без или с минимальными общими симптомами. Поражения кожи гетерогенны, что может также отсрочить верификацию диагноза.</p> <p>Представляем случай распространённого поражения кожных покровов анапластической крупноклеточной лимфомой, имитирующей рожистое воспаление, которая быстро прогрессировала от единичных высыпаний на коже запястья до обширного поражения правой молочной железы в течение одного месяца. До верификации диагноза пациентка получала лечение по поводу рожистого воспаления, пиодермии, а также опоясывающего герпеса без ответа на терапию. Иммуногистохимическое исследование биоптата кожи подтвердило диагноз ALK-негативной анапластической крупноклеточной лимфомы. На момент публикации пациентке выполнен первый курс химиотерапии по схеме CHOEP. Запланировано 6 циклов лечения по данной программе.</p> <p>Наш клинический случай подчёркивает необходимость широкой дифференциальной диагностики высыпаний, торпидных к проводимой терапии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cutaneous lymphoma</kwd><kwd>differential diagnosis</kwd><kwd>non-Hodgkin lymphoma</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лимфома кожи</kwd><kwd>дифференциальная диагностика</kwd><kwd>неходжкинская лимфома</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: Lymphoid neoplasms. Leukemia. 2022;36(7):1720–1748. doi: 10.1038/s41375-022-01620-2</mixed-citation><mixed-citation xml:lang="ru">Alaggio R., Amador C., Anagnostopoulos I., et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms // Leukemia. 2022. Vol. 36, N 7. P. 1720–1748. doi: 10.1038/s41375-022-01620-2</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Zain JM, Hanona P. Aggressive T-cell lymphomas: 2021 Updates on diagnosis, risk stratification and management. Am J Hematol. 2021;96(8):1027–1046. doi: 10.1002/ajh.26270</mixed-citation><mixed-citation xml:lang="ru">Zain J.M., Hanona P. Aggressive T-cell lymphomas: 2021 Updates on diagnosis, risk stratification and management // Am J Hematol. 2021. Vol. 96, N 8. P. 1027–1046. doi: 10.1002/ajh.26270</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Moodley N, Nombona P, Mosam A. Primary cutaneous anaplastic large-cell lymphoma. Dermatopathology. 2019;6(2):163–169. doi: 10.1159/000500259</mixed-citation><mixed-citation xml:lang="ru">Moodley N., Nombona P., Mosam A. Primary cutaneous anaplastic large-cell lymphoma // Dermatopathology. 2019. Vol. 6, N 2. P. 163–169. doi: 10.1159/000500259</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Vose J, Armitage J, Weisenburger D. International peripherial T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124–4130. doi: 10.1200/JCO.2008.16.4558</mixed-citation><mixed-citation xml:lang="ru">Vose J., Armitage J., Weisenburger D. International peripherial T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes // J Clin Oncol. 2008. Vol. 26, N 25. P. 4124–4130. doi: 10.1200/JCO.2008.16.4558</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol. 2013;85(2):206–215. doi: 10.1016/j.critrevonc.2012.06.004</mixed-citation><mixed-citation xml:lang="ru">Ferreri A.J., Govi S., Pileri S.A., Savage K.J. Anaplastic large cell lymphoma, ALK-negative // Crit Rev Oncol Hematol. 2013. Vol. 85, N 2. P. 206–215. doi: 10.1016/j.critrevonc.2012.06.004</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Shustov A, Cabrera ME, Civallero M, et al. ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project. Blood Adv. 2021;5, N 3. P. 640–648. doi: 10.1182/bloodadvances.2020001581</mixed-citation><mixed-citation xml:lang="ru">Shustov A., Cabrera M.E., Civallero M., et al. ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project // Blood Adv. 2021. Vol. 5, N 3. P. 640–648. doi: 10.1182/bloodadvances.2020001581</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Philippe E, Creech KT, Cook N, Segura J. Recurrent primary cutaneous anaplastic large cell lymphoma with systemic involvement: A case report and literature review. Cureus. 2021;13(4):e14284. doi: 10.7759/cureus.14284</mixed-citation><mixed-citation xml:lang="ru">Philippe E., Creech K.T., Cook N., Segura J. Recurrent primary cutaneous anaplastic large cell lymphoma with systemic involvement: A case report and literature review // Cureus. 2021. Vol. 13, N 4. Р. e14284. doi: 10.7759/cureus.14284</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Magro CM, Momtahen S, Kiuru M. Primary cutaneous small cell variant of anaplastic large cell lymphoma: A case series and review of the literature. Am J Dermatopathol. 2017;39(12):877–889. doi: 10.1097/DAD.0000000000000908</mixed-citation><mixed-citation xml:lang="ru">Magro C.M., Momtahen S., Kiuru M. Primary cutaneous small cell variant of anaplastic large cell lymphoma: A case series and review of the literature // Am J Dermatopathol. 2017. Vol. 39, N 12. P. 877–889. doi: 10.1097/DAD.0000000000000908</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Kempf W. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders. Semin Diagn Pathol. 2017;34(1):22–35. doi: 10.1053/j.semdp.2016.11.005</mixed-citation><mixed-citation xml:lang="ru">Kempf W. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders // Semin Diagn Pathol. 2017. Vol. 34, N 1. P. 22–35. doi: 10.1053/j.semdp.2016.11.005</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Chkhikvadze VD, Kolesnik AIu, Meskikh EV, Lagozhina IA. Edematous-infiltrative breast cancer: expediency of its division into primary and secondary forms. P.A. Herzen journal of Oncology. 2015;4(1):21–24. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Чхиквадзе В.Д., Колесник А.Ю., Меских Е.В., Лагожина И.А. Отечно-инфильтративный рак молочной железы: целесообразность разделения на первичную и вторичную формы // Онкология. Журнал им. П.А. Герцена. 2015. Т. 4, № 1. С. 21–24.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
